CMA OKs Al Mujtama Pharmacy's direct listing on Nomu

04/10/2023 Argaam
Logo ofCapital Market Authority

Logo of Capital Market Authority

The Capital Market Authority's (CMA) board approved, on Oct. 2, Al Mujtama Pharmacy's application for direct listing on Nomu-Parallel Market.

 

The offer will be confined to qualified investors stipulated in the glossary of defined terms used in the regulations and rules of the CMA. The prospectus will be published within sufficient time prior to the start of the offering.

 

The CMA's approval is valid for six months. It is deemed cancelled if the offering and listing are not completed within this period.

 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.